Perceptive Informatics announces the expansion of its medical imaging capabilities for cardiology clinical trials

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced that it has expanded its leading medical imaging capabilities with advanced nuclear imaging functionality for cardiology clinical trials. Perceptive has incorporated into its medical imaging technologies components of Hermes Medical Solutions Nuclear Medicine Software Suite and INVIA's Corridor4DM, a solution for nuclear cardiac quantification and imaging. The solutions allow Perceptive to better integrate several imaging modalities, including Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Multi Gated Acquisition Scan (MUGA) to enhance electronic processing, review, analysis, reporting, and archiving of medical images for cardiology trials.

The Hermes Medical Solutions Nuclear Medicine Software Suite provides the ability to display and reconstruct raw data sets using both back-projection and iterative methods for quantitative analysis. These solutions allow Perceptive to accept images from any scanner and assemble them into a standardized, consistent format for processing and review. Corridor4DM from INVIA offers quantification, review, and reporting of cardiac perfusion, function, and anatomy in 3-D. The system provides advanced processing algorithms and image display for greater diagnostic accuracy and quality assurance. These enhancements further expand Perceptive's capabilities for medical imaging-based cardiology trials, which include the use of DigiView, a specialized echocardiography image management and reporting system for cardiac function assessment.

"Perceptive is committed to continually incorporating innovative state-of-the-art technologies into our capabilities to help biopharmaceutical companies further improve the use of medical imaging as a surrogate endpoint, or biomarker. Key goals in expanding our capabilities with this advanced nuclear imaging functionality are to help customers make earlier safety and efficacy assessments and better decisions about their compounds in order to bring new cardiovascular treatments to patients sooner," said Kenneth G. Faulkner, Ph.D., Vice President of Medical Imaging, Perceptive Informatics.

The incorporation of technologies from Hermes Medical Solutions and INVIA supplements the medical imaging capabilities of Perceptive Informatics by providing solutions tailored for cardiology related trials, including specialized PET, SPECT, and MUGA techniques. The Medical Imaging Group of Perceptive Informatics offers a full range of capabilities in the application of imaging techniques from early clinical development through peri-approval studies. The medical imaging team operates globally and services a wide range of therapeutic areas, including oncology, neurology, rheumatology, cardiology, and endocrinology. Perceptive's medical imaging technologies are fully validated and in compliance with regulatory guidelines.